The nuclear imaging isotope shortage of molybdenum-99 (Mo-99) that was predicted to paralyze cardiac nuclear imaging may be over much sooner than expected. An update from the Nuclear Medicine Europe Emergency Response Team said its high-flux reactor (HFR) in the Netherlands has successfully restarted and the group anticipates that the normal global supply of Mo-99 will be achieved later this week.
